PDEX Pro-Dex, Inc. logo

PDEX Pro-Dex, Inc.

Healthcare
$65.15+2.57%ClosedMarket Cap: $208.0M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

14.32

PEG

0.21

P/B

4.50

P/S

2.72

EV/EBITDA

10.85

DCF Value

$133.34

FCF Yield

3.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

27.8%

Operating Margin

14.5%

Net Margin

16.1%

ROE

29.1%

ROA

16.0%

ROIC

12.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q3 null$19.9M$3.9M$
Q2 null$18.7M$2.2M$
Q1 null$18.5M$4.7M$
Q4 null$17.5M$1.2M$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell
Ascendiant CapitalBuy
2026-05-12
Ascendiant CapitalBuy
2025-05-27

Trading Activity

Insider Trades

View All
Domingo Angelita Rebamontandirector
SellFri Jan 23
Philp Katrina Marie Kramerdirector
SellMon Nov 24
Philp Katrina Marie Kramerdirector
SellMon Nov 24
Van Kirk Richard Lee Jrdirector, officer: Chief Executive Officer
SellFri Nov 21
Swenson Nicholas Johndirector, 10 percent owner:
SellFri Nov 21

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

US

Exchange

Beta

-0.11

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Peers